Medtronic (NYSE: MDT) has faced significant challenges, including a pandemic-induced slowdown, relatively slow revenue growth ...

Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, ...

We came across a bullish thesis on Medtronic plc (MDT) on Investing Intel’s Substack. In this article, we will summarize the ...

Medtronic upgraded to 'Strong Buy' with $104 fair value. Diabetes spin-off boosts focus on core markets, driving growth, ...

Medtronic (NYSE: MDT) announced some personnel moves, including the departure of a longtime leader across multiple business ...

Medtronic has unveiled plans to spin off its diabetes unit into its own publicly traded company that would be headquartered ...

Medtronic expects Trump administration tariffs and reciprocal tariffs from other countries to cost it $200–350 million over ...

His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Medtronic, a healthcare technology company based in Ireland, plans to separate its diabetes business into a standalone, publicly traded company by the end of 2026.  The company announced the move May ...

Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months ...

Medtronic (NYSE:MDT) reported better-than-expected fiscal Q4 earnings and revenue, while unveiling plans to spin off its ...